03Recent Activity
Portfolio company Recursion Pharmaceuticals completed a $436M IPO on NASDAQ.
APR 2021
Recursion Pharmaceuticals uses AI to discover new drugs, aiming to reduce the high failure rate of traditional drug discovery
Recursion Pharmaceuticals uses AI to discover new drugs, aiming to reduce the high failure rate of traditional drug discovery. They partner with industry leaders and leverage advanced data and machine learning models.